NasdaqGM - Nasdaq Real Time Price USD

Biodesix, Inc. (BDSX)

0.3716
+0.0238
+(6.84%)
At close: May 9 at 4:00:01 PM EDT
0.3991
+0.03
+(7.40%)
Pre-Market: 7:10:12 AM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
71,323
71,323
49,087
38,212
54,506
Cost of Revenue
15,573
15,573
13,010
14,154
30,518
Gross Profit
55,750
55,750
36,077
24,058
23,988
Operating Expense
90,010
90,010
77,375
74,564
63,306
Operating Income
-34,260
-34,260
-41,298
-50,506
-39,318
Net Non Operating Interest Income Expense
-8,258
-8,258
-9,536
-8,072
-4,508
Other Income Expense
-413
-413
-1,312
-6,869
667
Pretax Income
-42,931
-42,931
-52,146
-65,447
-43,159
Net Income Common Stockholders
-42,931
-42,931
-52,146
-65,447
-43,159
Diluted NI Available to Com Stockholders
-42,931
-42,931
-52,146
-65,447
-43,159
Basic EPS
-0.33
--
-0.64
-1.55
-1.58
Diluted EPS
-0.33
--
-0.64
-1.55
-1.58
Basic Average Shares
129,670
--
82,113
42,103
27,365
Diluted Average Shares
129,670
--
82,113
42,103
27,365
Total Operating Income as Reported
-34,498
-34,498
-41,342
-50,587
-40,940
Total Expenses
105,583
105,583
90,385
88,718
93,824
Net Income from Continuing & Discontinued Operation
-42,931
-42,931
-52,146
-65,447
-43,159
Normalized Income
-42,445
-42,445
-50,828
-58,469
-43,835
Interest Expense
8,258
8,258
9,536
8,072
4,508
Net Interest Income
-8,258
-8,258
-9,536
-8,072
-4,508
EBIT
-34,673
-34,673
-42,610
-57,375
-38,651
EBITDA
-29,217
-29,217
-37,103
-51,531
-35,473
Reconciled Cost of Revenue
15,573
15,573
13,010
14,154
30,518
Reconciled Depreciation
5,456
5,456
5,507
5,844
3,178
Net Income from Continuing Operation Net Minority Interest
-42,931
-42,931
-52,146
-65,447
-43,159
Total Unusual Items Excluding Goodwill
-486
-486
-1,318
-6,978
676
Total Unusual Items
-486
-486
-1,318
-6,978
676
Normalized EBITDA
-28,731
-28,731
-35,785
-44,553
-36,149
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 10/28/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

VCYT Veracyte, Inc.
29.71
-4.81%
 
MDXH MDxHealth SA
1.8700
+3.31%
 
CSTL Castle Biosciences, Inc.
16.79
-2.47%
 
XGN Exagen Inc.
5.71
-7.31%
 
MYGN Myriad Genetics, Inc.
3.8900
-3.47%
 
AWHL Aspira Women's Health Inc.
0.0700
-12.50%
 
NDRA ENDRA Life Sciences Inc.
3.2600
-46.99%
 
PSNL Personalis, Inc.
5.04
-2.33%
 
EYWN.HA BioMerieux SA
117.30
+0.60%
 
EYWN.F bioMérieux S.A.
117.10
+1.12%